KNOXVILLE, Tenn.--(BUSINESS WIRE)--iO Urology, a private medical device company revolutionizing urologic care through home-based diagnostics and management, is pleased to announce the appointment of Tyler Binney as Chairman of the Board of Directors.
Tyler joins iO Urology’s board with a strong track record of driving innovation and growth through strategic vision and operational expertise with over 20 years in the medical device industry. He currently serves as President and CEO of Relievant Medsystems, Inc., which was acquired by Boston Scientific in November 2023 for an upfront payment of $850 million plus performance based earnouts. Previously, he served as President and General Manager of Interventional Urology at Teleflex, where he played a key role in the $1.1 billion acquisition of NeoTract, Inc. in 2017.
“I am honored to lead iO Urology’s Board of Directors,” said Mr. Binney. “The company is on the brink of transforming urologic patient care by harnessing crucial data captured by patients at home to enhance the diagnosis and management of lower urinary tract symptoms. I look forward to working with this distinguished team and collaborating with management as we embark on the next phase of strategic growth.”
“We are thrilled to welcome Tyler as Chairman of our Board. His extensive leadership experience and impressive track record of commercializing disruptive technologies make him an invaluable addition to our team,” said Britton Garrett, Chief Executive Officer and board member. “Tyler’s appointment is a significant milestone in our journey to advance the future of urologic care. This announcement follows our successful Series A fund raise of $19.4 MM in Q1 of 2024.”
About iO Urology
iO Urology is dedicated to advancing patient outcomes by offering a convenient, accessible solution for managing urological conditions in the home. Using embedded cellular connectivity, the CarePath device provides reliable, accurate data that improves the diagnosis and management of lower urinary tract symptoms. Our mission is to develop and deliver cutting-edge solutions that address the complexities of urological conditions, enhancing both patient quality of life and clinical effectiveness. iO Urology strives to set new standards in the industry by empowering both patients and healthcare professionals with the knowledge they need to make informed decisions.
